New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More

Medical Properties Stock Rises 16% in 3 Months: Will the Trend Last?

By Zacks Equity Research | September 19, 2025, 1:43 PM

Shares of Medical Properties Trust MPW — also known as MPT — have gained 16.2% in the past three months, outperforming the industry’s growth of 0.9%.

This healthcare real estate investment trust (REIT), carrying a Zacks Rank #3 (Hold), is engaged in acquiring and developing net-leased healthcare facilities. Its properties consist of general acute care hospitals, behavioral health facilities, post-acute care facilities, freestanding ER/urgent care facilities and other assets.

 

Zacks Investment Research

Image Source: Zacks Investment Research

 

Let us decipher the possible factors behind the surge in the stock price.

The senior citizens’ population is expected to rise in the years ahead. As a result, the national healthcare expenditure by senior citizens, who constitute a major customer base of healthcare services and incur higher healthcare expenditures than the average population, will likely increase in the upcoming period.

Moreover, the healthcare sector is relatively immune to the macroeconomic problems faced by office, retail and apartment companies and offers stability to the company amid volatility in the market. This is because even amid tough economic conditions, consumers need to spend on healthcare services while curtailing discretionary purchases.

Medical Properties leases facilities to healthcare operating companies. These facilities generally have initial fixed lease terms of at least 15 years, with most including five-year renewal options. More than 99% of its leases provide annual rent escalations based on increases in the Consumer Price Index. In August 2025, MPT announced a lease agreement for six California facilities with NOR Healthcare System Corp. Subject to approval by applicable regulatory agencies, the deal is expected to close in 2025.

Strategic sell-outs provide the company with the dry powder to reinvest in opportunistic developments and redevelopments. During the first six months of 2025, Medical Properties sold three facilities and an ancillary facility for around $48 million, resulting in a gain on real estate of $13.3 million.

Medical Properties has been making efforts to enhance its liquidity position and financial strength. As of Aug. 5, 2025, the company had approximately $1.2 billion of liquidity. After the February 2025 refinancing transactions, the company has no debt maturities coming due in the next twelve months. Its access to diverse capital sources through capital recycling and internal cash flow provides ample financial flexibility and is likely to support its growth endeavors.

With the factors mentioned above, the positive trend in the stock is expected to continue in the near term.

Key Risks for MPW

Operator concentration risk, potential tenant bankruptcies and substantial debt burden remain concerns for Medical Properties. Any further reduction in dividend payouts will likely decrease shareholder value.

Stocks to Consider

Some better-ranked stocks from the broader REIT sector are Plymouth Industrial REIT PLYM and Crown Castle CCI, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for PLYM’s 2025 FFO per share has moved 2 cents northward to $1.88 over the past two months.

The Zacks Consensus Estimate for CCI’s 2025 FFO per share has moved 3 cents upward to $4.21 over the past two months.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Crown Castle Inc. (CCI): Free Stock Analysis Report
 
Medical Properties Trust, Inc. (MPW): Free Stock Analysis Report
 
Plymouth Industrial REIT (PLYM): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News